| 94256-5 |
Magnesium |
MCnc |
Sweat |
Pt |
Qn |
|
|
ACTIVE |
Magnesium [Mass/volume] in Sweat |
|
ADD |
DefinitionDescription |
|
|
mg/dl |
|
|
|
|
|
|
CHEM |
|
94256-5 |
|
|
|
|
Both |
|
|
|
0 |
Magnesium Sweat-mCnc |
|
|
|
|
|
Chemistry; Level; MAG; Magnes; Mass concentration; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random; SWT |
2.68 |
2.68 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 94257-3 |
PROMIS pediatric - global health 7 - version 1.0 |
- |
^Patient |
Pt |
- |
PROMIS.PEDS |
|
ACTIVE |
PROMIS pediatric - global health 7 - version 1.0 |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
PANEL.SURVEY.PROMIS |
|
94257-3 |
|
PROMIS.PEDS |
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS |
2.68 |
2.68 |
|
Panel |
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
|
|
0 |
| 94258-1 |
PROMIS pediatric - global health 7 - version 1.0 raw score |
Score |
^Patient |
Pt |
Qn |
PROMIS.PEDS |
|
ACTIVE |
PROMIS pediatric - global health 7 - version 1.0 raw score |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
SURVEY.PROMIS |
|
94258-1 |
|
PROMIS.PEDS |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS |
2.68 |
2.68 |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
{score} |
|
|
|
0 |
| 9426-8 |
Barbiturates |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Barbiturates [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L;mcg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9426-8 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Ur-mCnc |
|
|
|
Y |
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
| 94263-1 |
PROMIS pediatric - global health 7 - version 1.0 T-score |
Tscore |
^Patient |
Pt |
Qn |
PROMIS.PEDS |
|
ACTIVE |
PROMIS pediatric - global health 7 - version 1.0 T-score |
|
ADD |
DefinitionDescription |
|
|
Tscore |
|
|
|
|
|
|
SURVEY.PROMIS |
|
94263-1 |
|
PROMIS.PEDS |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score |
2.68 |
2.68 |
|
|
|
|
|
|
|
{Tscore} |
|
|
|
0 |
| 94264-9 |
Brucella sp Ab |
Titr |
CSF |
Pt |
SemiQn |
Aggl.capture |
|
ACTIVE |
Brucella sp Ab [Titer] in Cerebral spinal fluid by Immunocapture agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
94264-9 |
|
Aggl.capture |
|
|
Both |
|
|
|
0 |
Brucella Ab Titr CSF Capture aggl |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Capture aggl; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; SmQn; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Titer; Titered; Titre; Ttr |
2.75 |
2.68 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.69: COMPONENT: Corrected capitalization of first letter for "Ab"; |
0 |
| 94265-6 |
Cells.CD18 |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
CD18 cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
94265-6 |
|
|
|
|
Observation |
|
|
|
0 |
CD18 Cells Bld Ql |
|
|
|
|
|
Beta2; Beta-2 integrin; Beta-2 integrin chain; Blood; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; CD18 Cells; Cell; CELL MARKERS; Cellularity; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94266-4 |
CD11a & CD11b & CD18 phenotyping panel |
- |
Bld |
Pt |
Ord |
|
|
ACTIVE |
CD11a, CD11b, and CD18 phenotyping panel - Blood Qualitative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CELLMARK |
|
94266-4 |
|
|
|
|
Order |
|
|
|
0 |
CD11a + CD11b + CD18 Pnl Bld |
|
|
|
|
|
AlphaL integrin chain; AlphaM integrin chain; AlphaM-beta2; Beta2; Beta-2 integrin; Beta-2 integrin chain; Blood; C3biR; CD11a + CD11b + CD18 Pnl; CD11a beta subunit; CD11b beta subunit; CD11c beta subunit; CELL MARKERS; CR3; LAD-1; Leu15; Leu-15; Leukocyte Adhesion Deficiency Syndrome; Leukocyte adhesion deficiency syndrome type 1; LFA-1alpha; Mac-1; Mo1; Ordinal; Pan; PANEL.CELLMARK; Panl; Pheno; Phenotypic; Pnl; Point in time; QL; Qual; Qualitative; R3; Random; Screen; WB; Whole blood |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 94267-2 |
Cells.CD11b |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
CD11b cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
94267-2 |
|
|
|
|
Observation |
|
|
|
0 |
CD11b Cells Bld Ql |
|
|
|
|
|
AlphaM integrin chain; AlphaM-beta2; Blood; C3biR; CD11b Cells; Cell; CELL MARKERS; Cellularity; CR3; Leu15; Leu-15; Mac-1; Mo1; Ordinal; Point in time; PR; QL; Qual; Qualitative; R3; Random; Screen; WB; Whole blood |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94268-0 |
Cells.CD11a |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
CD11a cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CELLMARK |
|
94268-0 |
|
|
|
|
Observation |
|
|
|
0 |
CD11a Cells Bld Ql |
|
|
|
|
|
AlphaL integrin chain; Blood; CD11a Cells; Cell; CELL MARKERS; Cellularity; LFA-1alpha; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94269-8 |
Platelet aggregation.EPINEPHrine induced^50 umol/L |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --50 umol/L |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
94269-8 |
|
|
|
|
Both |
|
|
|
0 |
PA Epineph 50 umol/L PRP |
|
|
|
|
|
Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes |
2.68 |
2.68 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 9427-6 |
Barbiturates |
MCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Barbiturates [Mass/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9427-6 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Gast-mCnc |
|
|
|
Y |
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random |
2.34 |
1.0i |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 94270-6 |
Ubiquinone 10 |
SCnt |
WBC |
Pt |
Qn |
|
|
ACTIVE |
Coenzyme Q10 [Moles/mass] in Leukocytes |
|
ADD |
DefinitionDescription |
|
|
pmol/mg protein |
|
|
|
|
|
|
CHEM |
|
94270-6 |
|
|
|
|
Both |
|
|
|
0 |
Ubiquinone10 WBC-sCnt |
|
|
|
|
|
Cardio; Cardiology; Chemistry; Coenzyme Q10; CoQ10; CO-Q10; Heart Disease; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content; Ubiquinone10; WBCs; White blood cells |
2.68 |
2.68 |
|
|
|
|
|
|
|
pmol/mg{protein} |
|
|
|
0 |
| 94271-4 |
Purkinje cell cytoplasmic type 1 Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
Line blot |
|
ACTIVE |
PCA-1 IgG Ab [Presence] in Serum by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94271-4 |
|
Line blot |
|
|
Both |
|
|
|
0 |
PCA-1 IgG Ser Ql Line blot |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; i; Immune globulin G; Immunoglobulin G; Neuro; Neurology; Oncology; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Yo Ab |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94272-2 |
Purkinje cell cytoplasmic type 1 Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
Line blot |
|
ACTIVE |
PCA-1 IgG Ab [Presence] in Cerebral spinal fluid by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94272-2 |
|
Line blot |
|
|
Both |
|
|
|
0 |
PCA-1 IgG CSF Ql Line blot |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; i; Immune globulin G; Immunoglobulin G; Neuro; Neurology; Oncology; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Yo Ab |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94273-0 |
Muscle specific receptor tyrosine kinase Ab.IgG |
SCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Muscle specific receptor tyrosine kinase IgG Ab [Moles/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
SERO |
|
94273-0 |
|
IA |
|
|
Both |
|
|
|
0 |
MuSK IgG Ser IA-sCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immunoglobulin G; Inherited; Level; MEIA; Musc; Muscl; MuSK; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; Spec; SR; Substance concentration; SUDS; Tyr |
2.68 |
2.68 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 94274-8 |
Bedaquiline |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Bedaquiline [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
94274-8 |
|
|
|
|
Both |
|
|
|
0 |
Bedaquiline Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Extensively drug resistant tuberculosis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MDR TB; MDR Tuberculosis; Multi drug resistant tuberculosis; Point in time; Random; Sirturo; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; XDR TB |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94275-5 |
Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
94275-5 |
|
|
|
|
Both |
|
|
|
0 |
Honey bee (rApi m) 3 IgE Qn |
|
|
|
|
|
ABS; Aby; Ac Phos; Acd; Acid phosphatase.total; Acids; AcP; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honey bee (rApi m) 3; Honeybee; i001; i1; i215; III; Immune globulin E; Immunoglobulin E; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
2.68 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 94276-3 |
Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
94276-3 |
|
|
|
|
Both |
|
|
|
0 |
Honey bee DPP (rApi m) 5 IgE Qn |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honey bee DPP (rApi m) 5; Honeybee; i001; i1; i216; Immune globulin E; Immunoglobulin E; M5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
2.68 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 94277-1 |
Dog recombinant (rCan f) 6 Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Dog recombinant 6 IgE Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
94277-1 |
|
|
|
|
Both |
|
|
|
0 |
Dog (rCan f) 6 IgE Qn |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 6; e230; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
2.68 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 94278-9 |
Cat recombinant (rFel d) 7 Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cat recombinant (rFel d) 7 IgE Ab [Units/volume] in Serum |
|
ADD |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
94278-9 |
|
|
|
|
Both |
|
|
|
0 |
Cat (rFel d) 7 IgE Qn |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cat (rFel d) 7; Dextro; e231; Feline; Felis domesticus; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
2.68 |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 94279-7 |
Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Honey bee acid phosphatase recombinant (rApi m) 3 IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
94279-7 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Honey bee (rApi m) 3 IgE RAST Ql |
|
|
|
|
|
ABS; Aby; Ac Phos; Acd; Acid phosphatase.total; Acids; AcP; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honey bee (rApi m) 3; Honeybee; i001; i1; i215; IgE RAST; III; Immune globulin E; Immunoglobulin E; Ordinal; Phos; Phosphtase; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2.68 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 9428-4 |
Benzodiazepines |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Benzodiazepines [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
9428-4 |
|
|
|
|
Both |
|
|
|
0 |
Benzodiaz Ur-mCnc |
|
|
|
Y |
|
Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UniversalLabOrders; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 94280-5 |
Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Honey bee dipeptidyl peptidase recombinant (rApi m) 5 IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
94280-5 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Honey bee DPP (rApi m) 5 IgE RAST Ql |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honey bee DPP (rApi m) 5; Honeybee; i001; i1; i216; IgE RAST; Immune globulin E; Immunoglobulin E; M5; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2.68 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 94281-3 |
Dog recombinant (rCan f) 6 Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Dog recombinant 6 IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
94281-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Dog (rCan f) 6 IgE RAST Ql |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 6; e230; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2.68 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
